Case number 1:23-cv-00654
Hikma Pharmaceuticals USA Inc. v. Padagis Israel Pharmaceuticals Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 28, 2023 | 23 | NOTICE of withdrawal of Jonathan A. Choa by Padagis Israel Pharmaceuticals Limited, Padagis LLC, Padagis US LLC (Choa, Jonathan) (Entered: 12/28/2023) (1) |
| Dec 11, 2023 | 22 | Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 12/11/2023) (3) |
| Dec 8, 2023 | 21 | PROPOSED ORDER [Proposed] Consent Order of Dismissal by Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) (Entered: 12/08/2023) (2) |
| Nov 14, 2023 | 20 | SCHEDULING ORDER: Joinder of Parties due by 6/20/2024. Amended Pleadings due by 6/20/2024. Fact Discovery completed by 10/31/2024. Opening Expert Reports due by 12/12/2024. Rebuttal Expert Reports due by 1/16/2025. Reply Expert Reports due by 2/20/2025. Expert Discovery due by 4/3/2025. A Status Conference is set for 8/20/2024 at 03:00 PM before Judge Sherry R. Fallon. Status Report due by 8/14/2024. Claim Construction Opening Brief due by 5/10/2024. Claim Construction Answering Brief due by 6/7/2024. Claim Construction Reply Brief due by 6/28/2024. Claim Construction Surreply Brief due by 7/19/2024. Joint Claim Construction Brief due by 7/26/2024. A Markman Hearing is set for 9/25/2024 at 02:00 PM in Courtroom 6C before Judge Sherry R. Fallon. Proposed Pretrial Order due by 9/10/2025. A Pretrial Conference is set for 9/17/2025 at 03:00 PM in Courtroom 6B before Judge Gregory B. Williams. A 5-day Bench Trial is set to begin on 9/22/2025 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. IT IS FURTHER ORDERED that the scheduling teleconference set in this matter for today at 3:00 pm is CANCELLED. (PLEASE REFER TO ORDER FOR FURTHER DETAILS) Ordered by Judge Sherry R. Fallon on 11/14/2023. (lih) (Entered: 11/14/2023) (14) |
| Nov 9, 2023 | 19 | PROPOSED Scheduling Order re 18 Letter by Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) Modified on 11/9/2023 (lih). (Entered: 11/09/2023) (14) |
| Nov 8, 2023 | 18 | Letter to The Honorable Sherry R. Fallon from Dominick T. Gattuso, Esq. regarding Proposed Scheduling Order. (Gattuso, Dominick) Modified on 11/9/2023 (lih). (Entered: 11/08/2023) (1) |
| Oct 10, 2023 | 17 | ORAL ORDER SETTING RULE 16(b) CONFERENCE: IT IS HEREBY ORDERED that: (1) A scheduling teleconference pursuant to Fed. R. Civ. P. 16(b) will be held on November 14, 2023 at 3:00 P.M. (2) The parties are required to prepare for the teleconference by conferring on all matters under Rule 16 and D. Del. LR 16 and shall submit a proposed Scheduling Order to the Court no later than November 8, 2023. The Court's form of scheduling order is posted at https://www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon. Portions of the proposed scheduling order falling outside the scope of the referral to the Magistrate Judge (such as summary judgment motions, Daubert motions, pre-trial motions in limine, the pre-trial conference, and trial) shall conform with Judge Williams' form of scheduling order found at https://www.ded.uscourts.gov /judge/judge-gregory-b-williams. If the parties have any suggestions or modifications to the standard Scheduling Order, they may be included in the proposed order for consideration by the Court. (3) If any disputed issue exists regarding the proposed Scheduling Order, it shall be noted therein, along with the parties' proposed language on the issue for consideration by the Court. Ordered by Judge Sherry R. Fallon on 10/10/2023. (lih) (Entered: 10/10/2023) (0) |
| Oct 4, 2023 | 16 | ORAL ORDER REFERRING CASE TO Magistrate Judge Sherry R. Fallon: IT IS HEREBY ORDERED that the above-captioned case is referred to Magistrate Judge Sherry R. Fallon to hear and resolve all pre-trial matters up to and including expert discovery matters (but not including summary judgment motions, Daubert motions, pre-trial motions in limine, or the pre-trial conference), subject to 28 U.S.C. §636(b) and any further Order of the Court. ORDERED by Judge Gregory B. Williams on 10/4/23. (ntl) (Entered: 10/04/2023) (0) |
| Sep 26, 2023 | 15 | MOTION for Pro Hac Vice Appearance of Attorney Sharon Lin of Winston & Strawn LLP - filed by Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) (Entered: 09/26/2023) (4) |
| Sep 5, 2023 | 14 | ANSWER to 11 Answer to Complaint,, Counterclaim, Hikma's Answer to Padagis' Counterclaims by Hikma Pharmaceuticals USA Inc..(Gattuso, Dominick) (Entered: 09/05/2023) (26) |
| Aug 16, 2023 | 13 | MOTION for Pro Hac Vice Appearance of Attorney Christine J. Siwik, William A. Rakoczy and Gregory A. Duff - filed by Padagis Israel Pharmaceuticals Limited, Padagis LLC, Padagis US LLC. (Rovner, Philip) (Entered: 08/16/2023) (5) |
| Aug 14, 2023 | 11 | ANSWER to 1 Complaint, and Separate Defenses of Defendants, COUNTERCLAIM of Padagis Israel Pharmaceuticals Ltd against Hikma Pharmaceuticals USA Inc. by Padagis US LLC, Padagis Israel Pharmaceuticals Limited, Padagis LLC.(Rovner, Philip) (Entered: 08/14/2023) (30) |
| Aug 14, 2023 | 12 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Padagis LLC for Padagis Israel Pharmaceuticals Limited, Padagis US LLC filed by Padagis Israel Pharmaceuticals Limited, Padagis LLC, Padagis US LLC. (Rovner, Philip) (Entered: 08/14/2023) (1) |
| Jul 3, 2023 | 10 | Joint STIPULATION TO EXTEND TIME for Defendants to answer, move or otherwise respond to Plaintiff's Complaint to August 14, 2023 - filed by Padagis Israel Pharmaceuticals Limited, Padagis LLC, Padagis US LLC. (Rovner, Philip) (Entered: 07/03/2023) (2) |
| Jun 23, 2023 | N/A | SO ORDERED, re 8 MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, and Annie R. Steiner of Winston & Strawn LLP filed by Hikma Pharmaceuticals USA Inc. Signed by Judge Gregory B. Williams on 6/23/23. (ntl) (Entered: 06/23/2023) (0) |
| Jun 23, 2023 | N/A | Pro Hac Vice Attorney Jovial Wong for Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 06/23/2023) (0) |
| Jun 23, 2023 | N/A | Pro Hac Vice Attorney Charles B. Klein for Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 06/23/2023) (0) |
| Jun 23, 2023 | 9 | WAIVER OF SERVICE returned executed by Hikma Pharmaceuticals USA Inc.: For All Defendants. (Gattuso, Dominick) (Entered: 06/23/2023) (1) |
| Jun 21, 2023 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 06/21/2023) (0) |
| Jun 16, 2023 | 8 | MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, and Annie R. Steiner of Winston & Strawn LLP - filed by Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) (Entered: 06/16/2023) (6) |
| Jun 15, 2023 | 6 | SUMMONS Returned Executed by Hikma Pharmaceuticals USA Inc..Padagis US LLC served on 6/15/2023, answer due 7/6/2023. (Gattuso, Dominick) (Entered: 06/15/2023) (2) |
| Jun 15, 2023 | 7 | SUMMONS Returned Executed by Hikma Pharmaceuticals USA Inc..Padagis LLC served on 6/15/2023, answer due 7/6/2023. (Gattuso, Dominick) (Entered: 06/15/2023) (2) |
| Jun 14, 2023 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Padagis Israel Pharmaceuticals Limited, Padagis LLC, and Padagis US LLC (Filing fee $ 402, receipt number ADEDC-4158862.) - filed by Hikma Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A-E, # 2 Civil Cover Sheet)(jfm) (Entered: 06/14/2023) (Main Document) (16) |
| Jun 14, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 06/14/2023) (3) |
| Jun 14, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 3, 2023. Date of Expiration of Patent: August 26, 2034.Thirty Month Stay Deadline: 11/3/2025. (jfm) (Entered: 06/14/2023) (1) |
| Jun 14, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,722,510; 10,973,814; 11,135,155; 11,617,713; 11,628,139. (jfm) (Entered: 06/14/2023) (1) |
| Jun 14, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hikma Pharmaceuticals PLC for Hikma Pharmaceuticals USA Inc. filed by Hikma Pharmaceuticals USA Inc. (jfm) (Entered: 06/14/2023) (2) |
| Jun 14, 2023 | N/A | No Summons Issued. (jfm) (Entered: 06/14/2023) (0) |
| Jun 14, 2023 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Padagis Israel Pharmaceuticals Limited, Padagis LLC, and Padagis US LLC (Filing fee $ 402, receipt number ADEDC-4158862.) - filed by Hikma Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A-E, # 2 Civil Cover Sheet)(jfm) (Entered: 06/14/2023) (Exhibit A-E) (30) |
| Jun 14, 2023 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Padagis Israel Pharmaceuticals Limited, Padagis LLC, and Padagis US LLC (Filing fee $ 402, receipt number ADEDC-4158862.) - filed by Hikma Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A-E, # 2 Civil Cover Sheet)(jfm) (Entered: 06/14/2023) (Civil Cover Sheet) (2) |
